PTMeta-AnalysisJournal of rehabilitation medicine2022

Efficacy of repetitive transcranial magnetic stimulation for improving lower limb function in individuals with neurological disorders: A systematic review and meta-analysis of randomized sham-controlled trials.

Søren Krogh, Anette B Jønsson, Per Aagaard and 1 others

PMID 34913062

WHAT IT FOUND

Real rTMS added to rehabilitation improved walking and lower limb muscle strength more than sham, but had no clear effect on mobility or balance.

Over half of the comparisons the review planned to pool had no usable data, so the estimates are uncertain.

Key findings

01Across 8 trials and 344 people, real rTMS improved walking-related outcomes more than sham, a moderate effect (0.51).

02In 2 small trials of people with spinal cord injury (50 people), real rTMS produced a large improvement in lower limb muscle strength (effect size 0.99).

03There was no clear effect on mobility (0.19, p = 0.24, 5 trials) or on balance (0.16, p = 0.38, 4 trials).

STILL TO COME

How it was doneWhat they foundWhat it means for PTs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

Two-thirds of the trials did not describe how the randomisation sequence was generated and about three-quarters did not say how allocation was concealed, so the review judged a moderate to high risk of selection bias to be present. Only 11 of the 27 included trials provided data that could be pooled, and in every category except balance data could not be obtained for more than half of the identified comparisons. The authors say this means the pooled effects may be over- or under-estimated. The trials varied widely in who was treated, how long the intervention lasted, how many sessions were given and the stimulation settings used, and the gait results were moderately to substantially heterogeneous. The pooled effects are pre-to-post changes, not changes to last follow-up, because follow-up time points differed between trials. The authors note that an analysis to follow-up might have given different results. Samples were small to medium, and some results rest on one or two small trials, including the large muscle strength effect (2 trials, 50 people) and the freezing of gait effect. In several included trials rTMS was delivered alongside physical therapy, treadmill training or motor imagery practice, in both the real and the sham arms, so the pooled effects describe rTMS added to rehabilitation rather than rTMS on its own. No data could be pooled for people with multiple sclerosis or ALS, and the spasticity analysis rests on a single study, so the review says nothing about rTMS in those groups.

Declared interests

The paper declares that the authors have no conflicts of interest. No funding source or sponsor is stated in the text provided.

The easy way to misread this

Do not read this as proof that rTMS works for walking. Data could be pooled from only 11 of the 27 trials, more than half of the comparisons the review identified had no usable results, and most trials did not report how patients were allocated to real or sham stimulation, so the pooled effects may be over- or under-estimated. The review also found no effect on mobility or balance, and the strong muscle strength result rests on two small spinal cord injury trials.

Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →


The study

Participants
27 randomised trials included; 11 supplied data that could be pooled (gait analysis: 344 participants)
Certainty of evidence
Moderate

More in neurological

Browse

Cite

Søren Krogh, Anette B Jønsson, Per Aagaard, et al. Efficacy of repetitive transcranial magnetic stimulation for improving lower limb function in individuals with neurological disorders: A systematic review and meta-analysis of randomized sham-controlled trials. Journal of rehabilitation medicine. 2022.

Read the original — we summarise, we never replace the paper.